Urgent.News

What's breaking now, across thousands of outlets.

More in Health & Medicine

GC Cell Publishes Glioblastoma CIK Study

Academic evidence has been established for the utilization of Cytokine-Induced Killer (CIK) cells in the treatment of glioblastoma (GBM), a representative malignant brain tumor occurring in adults.

  • GC Cell study on CIK cells published in Frontiers in Neurology on October 1st
  • Median progression-free survival of 10.5 months, median overall survival of 14.2 months
  • No treatment discontinuation due to adverse reactions, no severe allergic reactions or fatalities

More from Thursday 1 October →